Building A Scalable Digital Foundation To Support CGT Manufacturing

Cell and gene therapy manufacturing is reaching a pivotal moment. As organizations push toward commercial scale, many are discovering that paper-driven systems simply can’t keep pace with batch‑of‑one production, patient‑specific material variability, and the unforgiving time constraints that define CGT workflows. Even small delays can compromise a patient’s eligibility, making operational precision non‑negotiable.

Explore the digital foundations that leading manufacturers are using to control complexity while accelerating safe, timely batch release. It outlines a clear progression from basic digital record‑keeping to fully integrated manufacturing ecosystems that unify data, enhance chain‑of‑identity protection, and support patient‑proximate production models.

If you're building or scaling CGT operations, gain insight into the capabilities that matter most and the practical steps for achieving them.